Retraction: Microbiome-based hypothesis on Ivermectin's mechanism in COVID-19: Ivermectin feeds bifidobacteria to boost immunity [PDF]
Frontiers Editorial Office
openalex +1 more source
The efficacy of Ivermectin against strongyles in yearlings on Thoroughbred breeding farms in New Zealand [PDF]
Bolwell, C F +4 more
core +2 more sources
Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya [PDF]
Menno R. Smit +13 more
openalex +1 more source
Albendazole and Mebendazole Administered Alone or in Combination with Ivermectin against Trichuris trichiura: A Randomized Controlled Trial [PDF]
Background. Single-dose albendazole and mebendazole show limited efficacy in the treatment of trichuriasis. The combination of albendazole with ivermectin improves efficacy, but a mebendazole-ivermectin combination has not been previously investigated ...
Hattendorf, Jan +9 more
core +1 more source
Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?
Manuel Lorenzo López Reboiro +2 more
openalex +2 more sources
Toxicity assessment of four pharmaceuticals in aquatic environment before and after ferrate(VI) treatment [PDF]
Jiang, Jia-Qian +2 more
core +1 more source
Assessment of parasite control and weight gain after use of an ivermectin sustained-release bolus in calves [PDF]
William G. Ryan +3 more
openalex +1 more source
Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use [PDF]
Hideharu Hagiya, Fumio Otsuka
openalex +1 more source
Helminth parasites of sheep and goats in Eastern Ethiopia [PDF]
A two-year epidemiology study of helminths of small ruminants involved the collection of viscera from 655 sheep and 632 goats from 4 abattoirs in eastern Ethiopia.
Sissay, Menkir Mekonnen
core
The increased incidence of dengue poses a substantially global public health challenge. There are no approved antiviral drugs to treat dengue infections.
Junjie Ding +15 more
doaj +1 more source

